Want to see MIR full AI Analyst Report?
MIR Stock Chart & Stats
$14.85
-$0.34(-2.01%)
At close: 4:00 PM EDT
$14.85
-$0.34(-2.01%)
Day’s Range― - ―
52-Week Range$14.04 - $30.28
Previous CloseN/A
Volume2.32M
Average Volume (3M)4.04M
Market Cap
$4.05B
Enterprise Value$5.79B
Total Cash (Recent Filing)$425.30M
Total Debt (Recent Filing)$1.23B
Price to Earnings (P/E)164.1
Beta1.56
Next Earnings
Nov 03, 2026EPS Estimate
0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.10
Shares Outstanding243,278,090
10 Day Avg. Volume4,796,694
30 Day Avg. Volume4,040,360
Financial Highlights & Ratios
PEG Ratio-1.05
Price to Book (P/B)2.89
Price to Sales (P/S)5.82
P/FCF Ratio50.38
Enterprise Value/Market Cap1.43
Enterprise Value/Revenue5.65
Enterprise Value/Gross Profit11.76
Enterprise Value/Ebitda26.89
Forecast
1Y Price Target
$23.50Price Target Upside58.25% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
EPS Forecast (FY)0.55
Revenue Forecast (FY)$1.14B
Bulls Say, Bears Say
Bulls Say
Backlog VisibilityThe substantial backlog provides durable revenue visibility and reduces dependence on near-term order volatility. Coverage of most full-year expectations also supports planning, capacity utilization, and confidence that recent demand can translate into revenue over coming quarters.
Strong Cash GenerationMaterially positive operating and free cash flow strengthens Mirion’s ability to fund product investment, integrate acquisitions, reduce debt, and return capital without relying solely on external financing. The improvement from weaker prior years indicates better cash-generation momentum.
Nuclear Power DemandStrong nuclear orders point to structural demand from installed-base upgrades, plant life extensions, small modular reactors, and digital transformation. These applications align with Mirion’s specialized safety role and can support multi-year growth across products, systems, and services.
Bears Say
Thin ProfitabilityAlthough profitability has improved, low net and operating margins leave limited protection if demand softens or costs rise. The history of losses also suggests earnings power is still developing, which may constrain internally funded growth and make results more sensitive to execution.
Medical Segment WeaknessWeakness across medical and dosimetry offsets stronger nuclear momentum and makes the company’s growth mix less balanced. Delayed hardware demand and negative dosimetry growth could pressure organic expansion and require successful execution in other businesses to sustain consolidated results.
Backlog Conversion RiskA large backlog does not eliminate the risk that major projects convert later than expected. Slippage or government timing changes could shift revenue, cash flow, and margins between periods, complicating execution and reducing the near-term reliability of reported growth.
MIR FAQ
What was Mirion Technologies’s price range in the past 12 months?
Mirion Technologies lowest stock price was $14.04 and its highest was $30.28 in the past 12 months.
What is Mirion Technologies’s market cap?
Mirion Technologies’s market cap is $4.05B.
When is Mirion Technologies’s upcoming earnings report date?
Mirion Technologies’s upcoming earnings report date is Nov 03, 2026 which is in 21 days.
How were Mirion Technologies’s earnings last quarter?
Mirion Technologies released its earnings results on Jul 28, 2026. The company reported $0.12 earnings per share for the quarter, beating the consensus estimate of $0.103 by $0.017.
Is Mirion Technologies overvalued?
According to Wall Street analysts Mirion Technologies’s price is currently Undervalued.
Does Mirion Technologies pay dividends?
Mirion Technologies does not currently pay dividends.
What is Mirion Technologies’s EPS estimate?
Mirion Technologies’s EPS estimate is 0.12.
How many shares outstanding does Mirion Technologies have?
Mirion Technologies has 243,278,090 shares outstanding.
What happened to Mirion Technologies’s price movement after its last earnings report?
Mirion Technologies reported an EPS of $0.12 in its last earnings report, beating expectations of $0.103. Following the earnings report the stock price went down -13.222%.
Which hedge fund is a major shareholder of Mirion Technologies?
Currently, no hedge funds are holding shares in MIR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Mirion Technologies Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$23.50 (58.25% Upside)
$23.50 (58.25% Upside)
Blogger Sentiment
Bullish
MIR Sentiment 67%
Sector Average 64%
Sector Average 64%
Hedge Fund Trend
Decreased
By 21.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $312.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 16.5%
Last 30 Days ▲ 19.9%
Last 30 Days ▲ 19.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-29.71%
12-Months-Change
Fundamentals
Return on Equity
1.33%
Trailing 12-Months
Asset Growth
28.61%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Mirion Technologies
Mirion Technologies, Inc., established in 2005 and formerly known as Global Monitoring Systems, Inc. until its name change in January 2006, is based in Atlanta, Georgia. The company specializes in providing a comprehensive suite of specialized solutions for radiation detection, measurement, analysis, and monitoring. Its operations span a wide international footprint, covering countries such as the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, and Japan. The business is organized into two distinct operating segments: Medical and Industrial. The Medical segment delivers critical solutions aimed at enhancing patient safety and treatment accuracy within healthcare environments. Offerings here include quality assurance and dosimetry tools for radiation oncology, specialized patient safety systems for diagnostic imaging and radiation therapy centers, and precision calibration and verification solutions for medical imaging and treatment accuracy. Furthermore, it supplies radionuclide therapy products, which encompass shielding, handling equipment, dedicated medical imaging furniture, and rehabilitation aids for nuclear medicine applications. This segment fundamentally supports advancements in medical diagnostics, cancer treatment, professional safety for practitioners, and patient recovery. Conversely, the Industrial segment addresses vital requirements in radiation safety, measurement, and analysis across non-medical industries. It furnishes clients with personal radiation detection devices, identification equipment, and advanced analytical instrumentation. Mirion's extensive product and solution portfolio includes a variety of items such as nuclear medicine preparations, personal dosimeters, contamination and clearance monitoring systems, and sophisticated reactor instrumentation and control equipment. They also provide both medical and industrial imaging systems along with their related accessories, in addition to specialized instruments for alpha spectroscopy, alpha/beta counting, and gamma spectroscopy detector systems. Supplementary offerings include electrical penetration components, cancer diagnostic tools, software solutions, and a range of other services. Mirion serves a broad and varied clientele across numerous sectors. This includes healthcare providers like hospitals, clinics, urgent care facilities, dental and veterinary offices, and specialized radiation treatment centers, as well as original equipment manufacturers (OEMs) for radiation therapy. Beyond healthcare, their customers extend to research laboratories, military organizations, governmental agencies, various industrial enterprises, power and utility companies, reactor design firms, and nuclear power plants (NPPs).
MIR Company Deck
MIR Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial momentum driven by substantial backlog and order growth (notably in nuclear power and SMRs), expanding adjusted EBITDA margins, robust free cash flow, successful integration of Paragon, and maintained full-year guidance with good revenue coverage. Offsetting risks include weak organic revenue (medical softness and dosimetry declines), an $18M China debooking, M&A-related margin dilution, and timing/execution risk on large opportunities. On balance the positive drivers (backlog growth, margin expansion, cash generation, large wins, AI/product innovation) materially outweigh the near-term challenges, supporting constructive outlook for the remainder of 2026.View all MIR earnings summariesMIR Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$23.50
▲(58.25% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Babcock & Wilcox Company
―
Graham
―
Hadron Energy
―
X-Energy, Inc. Class A
―
Deep Fission
―
Ownership Overview
4.47% Insiders
32.79% Mutual Funds
2.65% Other Institutional Investors
29.84% Public Companies and
Individual Investors







